Daewoong Pharmaceutical is set to initiate Phase 1 clinical trials early next year, with the goal of commercializing the product by 2028
This dual benefit has made Ozempic a popular choice among patients seeking both diabetes control and weight management
Research has demonstrated that obesity is associated with increased risk of type 2 diabetes, heart disease, stroke, sleep apnea, hypertension, and certain cancers
The practical implication for travel is significant
Gradual return to normal activities is encouraged
With an interdisciplinary focus, practitioners utilize ophthalmic imaging, neuroimaging, laboratory evaluation, electrophysiology, pathologic evaluation, and genetic testing to evaluate patients